Cite

HARVARD Citation

    Rossignol, J. et al. (2022). A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19. EClinicalMedicine. p. . [Online]. 
  
Back to record